Other data revealed the involvement of IL-22Fc therapy in liver regeneration by reprogramming the regenerative pathways and attenuation of bacterial infection that ameliorated ACLF, which suggests the therapeutic potential for IL-22 in these patients (127). The gene discussed is IL22; the disease is bacterial infectious disease.